Ganoderma mushrooms have a variety of pharmacological activities and may have antitumor effects. Therefore, the antitumor activity of the methanolic fruiting body extracts of three Ganoderma spp. will be evaluated by estimating cell viability, cell cycle parameters and the mode of cellular death. In this regard, Sulfo-rhodamine B staining and flow cytometry were used. Hepatocellular carcinoma (HepG2) and breast ductal carcinoma (T-47D) cell lines were used as cancer models, while mouse normal liver (BNL) and oral epithelial cell (OEC) lines were used as respective controls. The results revealed that Ganoderma resinaceum extract decreased the viability of BNL at an IC50 > 100 µg/mL but not that of HepG2 at an IC50 of 72.32 µg/mL. Additionally, Ganoderma australe and Ganoderma mbrekobenum decreased the viability of OEC cell line at an IC50 of 328.29 and 271.56 µg/ mL, respectively. On the other hand, the IC50 of T-47D were 221.95 and 236.45 µg/mL, respectively. The three extracts arrested the cell life cycle at the G1 phase in each case. G. resinaceum extract stimulated total apoptosis (Q2 + Q4) of 19.99% with low necrosis (Q1). However, the percentages of total cell necrosis in the T-47D cell line treated with the other two extracts were 31.10% and 18.28%, respectively while the percentages of total cell apoptosis were 6.83% and 1.78%, respectively. Thus, G. resinaceum significantly inhibited the viability of the HepG2 cell line, while both the G. australe and G. mbrekobenum extracts significantly decreased the viability of the T-47D cell line. These results may encourage speculation about their possible use for the therapeutic management of hepatocellular carcinoma and breast ductal carcinoma after further investigation.
This study aimed to extract neem leaves components to determine their antimicrobial and antioxidants activities. In addition, their ability to suppress the proliferation of A549 and MCF-7 cells were studied to explore the possible underlying mechanisms involved during such effects. Therefore, the antimicrobial activity of the extract towards some bacterial and fungal strains was investigated using agar well diffusion method, minimum inhibition concentration (MIC) test, peroxidase (POX), and catalase (CAT) activities. Superoxide dismutase (SOD) and catalase (CAT) like activities as well as total antioxidant capacity (TAC) and DPPH scavenging activity were determined. Cells viabilities were also measured by the mitochondrial-dependent reduction of MTT on A549 and MCF-7 cell lines. Cell cycle was flowcytomerically analyzed to detect which phase was arrested. Quantitative real-time PCR (RT-PCR) was done to assess the changes in apoptotic and anti-apoptotic genes. Results showed that, neem leaves extract was more effective towards Gram-negative bacteria ( E. aerogenes and E. coli ) than that of Gram-positive type ( B. cereus and S. epidermidis ). Also, the extract has a high antioxidant activity compared to that of the ascorbic acid (DPPH IC 50 was 0.22 and 0.51 mg/ml for extract and ascorbic acid, respectively). Cytotoxicity assays confirm that the extract is able to suppress the proliferation of cell lines in a dose-dependent manner with IC 50 of 128.1 and 55.7 µg/ml for A549 and MCF-7, respectively. The extract promotes arrest of cell cycle at G0, inhibited the anti-apoptotic genes and stimulated the pro-apoptotic ones. In conclusion, neem leaves extract could have promising roles in pharmaceutical and medical applications.
Cancer continues to pose one of the biggest health burdens. Liver cancer has difficulties with early detection, efficient treatment and treatment resistance. Zeolitic imidazole framework-8(ZIF-8) is a type of metal organic frameworks (MOFs) that has a lot of useful properties; including its structural flexibility, high porosity and adjustable pore sizes, these make such framework good for drug delivery for hepatocellular carcinoma (HCC) and breast cancer. In the present study, curcumin was loaded into ZIF-8, and hyaluronic acid was applied as coat in a step-by-step, molar ratio, and pH-dependent manner. The resulting curcumin-loaded ZIF-8 (CZIF-8) and curcumin-loaded ZIF-8 coated with hyaluronic acid (CZIF-8/HA) nanocomposites were characterized by zeta potential, SEM, TEM, and PXRD. The obtained irregular semi-spherical nanocomposites have an average particle size of 127.93 and 131.07 nm; respectively. Also, their anticancer activities against two cancerous cell lines (HepG-2 and MDA-MB-231) and non-cancerous cell line (MCR-5) were assessed in vitro along with reference drug such as doxorubicin using the MTT assay. Additionally, the mechanisms by which these nanocomposites kill these tumor cells were found to involve apoptosis (elevated caspase-3 expression) rather than necrotic one and cell cycle arresting at G1/S phase. These particles have lower IC 50; particularly against HepG-2. Further, CZIF-8/HA demonstrated significantly higher cytotoxicity against cancer cells (HepG-2 and MDA-MB-231) compared to CZIF-8 and doxorubicin, while exhibiting minimal toxicity toward normal MRC-5 cells. These results imply that ZIF-8/HA is a promising nanocarrier for curcumin administration and could be used as a therapeutic strategy for breast and liver cancer treatment.
20 May 2023 in Scientific Journal for Damietta Faculty of Science
One of the most crucial nanomaterials used in applications of biomedicine is Multi-Walled Carbon nanotubes (MWCNTs). It is applicable in delivering of different drugs to the tumor target sites, including doxorubicin (DOX). This is because the functionalized MWCNTs can penetrate membranes with low cytotoxicity. In this study, MWCNTs were oxidized (Ox-MWCNTs) to improve their solubility and biocompatibility. Their abilities to encapsulate DOX were tested (Ox-MWCNT/DOX). These particles were then characterized using FTIR, TEM, SEM and zeta size. Their antitumor activities against in-vitroMCF-7 and NBL cells were estimated. The results of FTIR confirmed the addition of carboxyl groups to the MWCNTs followed by encapsulation of DOX.Their shape was tubular with open ends using TEM. From their surface view, SEM showed the tubes as hollow spheres with interconnected structure. Higher releasing rate of DOX at pH 5.8 comparing with pH 7.4 was observed. Treating of human breast cancer cells(MCF-7) with Ox-MWCNT/DOX resulted in cellular viabilities of 96±0.37, 87±0.7, 34.7±0.75, 14.3±1 and 4.2±0.5 % at doses equivalent to 0.1, 1, 10, 100 and 1000µg/ml free DOX, respectively. Moreover, higher viabilities (99.8±0.13, 99.54±0.69, 77.42±1.13, 62.48±0.1 and 55.3±1.25%) with lower cytotoxicities of normal liver cells(NBL) were observed under the same treatment protocol. Therefore, the investigated loading protocol may be a promising one for the treatment of such tumor type after further studies in the future.
22 May 2023 in Scientific Journal for Damietta Faculty of Science
Background: Males with cystic fibrosis (CF) are infertile. Congenital bilateral absence of the vas deferens (CBAVD) is one of the causes. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations have also been found to be an additional cause of male infertility. Therefore, the aims of this study were to investigate the possible involvement of five common CFTR gene mutations (ΔF508, G551D, G542X, W1282X, and R117H) in azoospermia Egyptian infertile males. Materials and Methods: Blood samples were collected from 32 infertile males with Azoospermia In addition, 25 healthy and fertile individuals were included. Fresh semen samples were analyzed by using computer-assisted sperm analysis (CASA). The hormonal profile was investigated using Immulite 2000. Further, screening for CFTR gene mutations were detected by using the Amplification-Refractory Mutation System (ARMS)-PCR technique. Results: Heterozygous CFTR mutations were detected in 4 patients among the studied 32 (12.5%) azoospermic individuals. ΔF508 and R117H are the only 2 detected mutations that gave positive results. Their incidences were 9.4% and 3.1%, respectively. On the hormonal levels, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were increased with no simultaneous effects on the testosterone level; a finding which supports testicular insufficiency rather than the CFTR gene. Conclusion: Whether the latter negatively contributes to azoospermia or not still needs further investigations; on a large-scale male sample. At this time, the importance of CFTR gene mutations study in Egyptians will be more valuable.
4 July 2023 in Scientific Journal for Damietta Faculty of Science
Congenital bilateral absence of the vas deferens (CBAVD) accounts for 2-6 percent of male infertility and up to 25 percent of incidences of obstructive azoospermia (OA). Men having azoospermia, teratozoospermia, and oligo asthenospermia had nonobstructive azoospermia (NOA). The relationship between cystic fibrosis transmembrane conductance regulator (CFTR) mutations and poor sperm quality remains to be controversial. In this review, the structure and function of CFTR gene mutations, their classes, their role in spermatogenesis, growth of vas deference, and their relation with CBAVD as well as with non-obstructive azoospermia will be included. Also, techniques for assisted reproductive technology (ART) will be simplified. Finally, the frequency of CFTR mutations in infertile males. Among them, German, Iranian, Chinese, Saudi Arabia, and Egyptian studies will be included. A discussion of their results will be done. The correlations of the results of these studies with the Egyptian ones will be summarized. Therefore, after intracytoplasmic sperm injection (ICSI) therapy, one can expect a higher frequency of CFTR mutations. The latter may increase the prevalence of cystic fibrosis (CF) in the patient’s offspring. All patients with CBAVD should urgently undergo CFTR mutations screening, especially during pre-ICSI genetic counseling.